A. Szántó

发表

Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.

A. Vissink, D. Isenberg, J. Sánchez-Guerrero, 2021, Clinical and experimental rheumatology.

Genome‐scale Assessment of Molecular Pathology in Systemic Autoimmune Diseases using Microarray Technology: A Potential Breakthrough Diagnostic and Individualized Therapy‐design Tool

G. Szegedi, B. Nakken, R. Jonsson, 2006, Scandinavian journal of immunology.

Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: Computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases.

M. Papp, A. Szántó, N. Sipeki, 2020, Clinica chimica acta; international journal of clinical chemistry.

Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.

D. Isenberg, M. Rotte, W. Ng, 2020, The Lancet. Rheumatology.

A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus

G. Papp, M. Zeher, A. Szántó, 2016, Clinical and experimental immunology.

Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.

P. Szodoray, M. Zeher, A. Szántó, 2006, Human immunology.

The Imbalance of Circulating Follicular T Helper Cell Subsets in Primary Sjögren’s Syndrome Associates With Serological Alterations and Abnormal B-Cell Distribution

B. Nakken, P. Szodoray, G. Papp, 2021, Frontiers in Immunology.

Decreased human paraoxonase-1 activity in patients with Sjögren's syndrome.

G. Paragh, M. Zeher, A. Szántó, 2010, International immunology.

Treatment of hypertension in patients with rheumatic diseases

D. Páll, C. Farsang, A. Szántó, 2013 .

Treatment of hypertension in patients with rheumatic diseases

D. Páll, C. Farsang, A. Szántó, 2013 .

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.

J. Sánchez-Guerrero, X. Mariette, S. Bombardieri, 2019, Clinical and experimental rheumatology.

Clinical Course, Prognosis, and Cause of Death in Primary Sjögren's Syndrome

G. Papp, M. Zeher, I. Horváth, 2014, Journal of immunology research.

Intrapulmonary Rheumatoid Nodules in a Patient with Long-Standing Rheumatoid Arthritis Treated with Leflunomide

P. Szodoray, M. Zeher, I. Horváth, 2008, Pathology & Oncology Research.

Functional and morphological evaluation of hand microcirculation with nailfold capillaroscopy and laser Doppler imaging in Raynaud's and Sjögren's syndrome and poly/dermatomyositis

P. Szodoray, M. Zeher, A. Szántó, 2008, Scandinavian journal of rheumatology.

Follicular helper T cells may play an important role in the severity of primary Sjögren's syndrome.

G. Papp, M. Zeher, K. Szabó, 2013, Clinical immunology.

Characterization and Comparison of Patient Subgroups Suspicious for IgG4-Related Disease and Malignant Lymphoma in Patients Followed-up for Sjögren’s Syndrome

G. Nagy, K. Szabó, M. Zeher, 2016, Pathology & Oncology Research.

Autoantibodies to alfa-fodrin in patients with Hashimoto thyroiditis and Sjögren’s syndrome: possible markers for a common secretory disorder

P. Szodoray, M. Zeher, I. Horváth, 2008, Rheumatology International.

Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.

A. Vissink, D. Isenberg, X. Mariette, 2021, Rheumatology.

Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.

A. Vissink, D. Isenberg, J. Gottenberg, 2020, Clinical and experimental rheumatology.

Autoimmune thyroid diseases in a large group of Hungarian patients with primary Sjögren's syndrome.

P. Szodoray, M. Zeher, I. Horváth, 2009, Thyroid : official journal of the American Thyroid Association.

Autoantibodies to novel membrane and cytosolic antigens of the lachrymal gland in primary Sjögren’s syndrome

B. Nakken, P. Szodoray, M. Zeher, 2008, Clinical Rheumatology.

Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren's syndrome.

M. Zeher, A. Szántó, I. Csípő, 2005, The Journal of rheumatology.

Sensitivity and specificity of anti-alpha-fodrin antibodies in primary Sjögren ' s

M. Zeher, A. Szántó, I. Csípő, 2005 .

Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells

E. Csoma, A. Bácsi, A. Szántó, 2022, International journal of molecular sciences.

Lack of association of vitamin D receptor gene polymorphisms/haplotypes in Sjögren’s syndrome

G. Papp, M. Zeher, A. Szántó, 2014, Clinical Rheumatology.

Hodgkin’s Lymphoma Developed after Autologous Stem Cell Transplantation for Multiple Myeloma

M. Zeher, G. Méhes, A. Szántó, 2012, Pathology & Oncology Research.

Description of patients with IgG4-related disease from a Hungarian centre

G. Nagy, M. Zeher, A. Szántó, 2014, Scandinavian journal of rheumatology.

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients

A. Vissink, F. Giardina, D. Isenberg, 2020, Rheumatology.

M. Zeher, A. Szántó, G. Szegedi, 2015, Lupus.

Long-term BCG immune therapy of superficial bladder tumours

A. Szántó, F. Baranyay, L. Somogyi, 2006, International Urology and Nephrology.

Regulation of RLR-Mediated Antiviral Responses of Human Dendritic Cells by mTOR

A. Bácsi, Krisztián Bene, A. Szántó, 2020, Frontiers in Immunology.

Methylene blue as a means of treatment for priapism caused by intracavernous injection to combat erectile dysfunction

A. Szántó, J. Hübler, K. Könyves, 2004, International Urology and Nephrology.

Late results of 1000 mitral commissurotomies.

A. Szántó, J. Kudász, I. Littmann, 1961, Cor et vasa.

Central Nervous System Involvement in Primary Sjögren’s Syndrome: Narrative Review of MRI Findings

E. Berényi, M. Emri, I. Horváth, 2022, Diagnostics.

[Association of systemic lupus erythematosus and Sjögren's syndrome].

M. Zeher, A. Szántó, G. Szegedi, 2005, Orvosi hetilap.

Novel aspects of muscle involvement in immune-mediated inflammatory arthropathies and connective tissue diseases.

A. Szántó, G. Szűcs, Z. Szekanecz, 2023, Autoimmunity reviews.

Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection

V. Devauchelle-Pensec, A. Sisó-Almirall, B. Armağan, 2021, Clinical and Experimental Rheumatology.

Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies.

A. Vissink, D. Isenberg, X. Mariette, 2022, Rheumatology.

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

A. Vissink, X. Mariette, S. Bombardieri, 2023, eClinicalMedicine.

Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection.

V. Devauchelle-Pensec, A. Sisó-Almirall, B. Armağan, 2021, Clinical and experimental rheumatology.

A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren's syndrome and systemic lupus erythematosus

G. Papp, M. Zeher, A. Szántó, 2016, Clinical and experimental immunology.